Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...

ICER has published the research protocol (PDF) for the evaluation of Breo Ellipta and Trelegy Ellipta ... to their respective fixed-dose generic alternatives or open generic combinations ...

According to the Schmidtknechts, OptumRx forces patients to fill prescriptions with expensive brand-name drugs when cheaper alternatives ... cover Advair HFA or Breo Ellipta, two newer brand ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its respiratory blockbuster Advair/Seretide, but won’t come close to ...

Finally, the developers of Ungoogled Chromium Browser have stripped all binaries from the source code and replaced them with user-provided alternatives. Ungoogled Chromium Browser is free and can ...

The article provides several healthier alternatives to heavy cream that can be used in various recipes without sacrificing flavor. These substitutes, including coconut milk, Greek yogurt ...

Innoviva is entitled to receive royalties from GSK on sales of RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®. Innoviva’s other innovative healthcare assets include infectious disease and ...

Sales of Advair/Seretide and Anoro Ellipta fell 2% each. Revlar/Breo Ellipta sales declined 5%. The decline in vaccine sales was primarily due to lower sales of its RSV vaccine Arexvy. The figure ...

GRAND RAPIDS, Mich. — Different fires, same cause say Grand Rapids Fire Department officials, making for a busy Tuesday evening. The first call came in just before 6 p.m. on Veto St NW near ...

As China’s DeepSeek threatens to dismantle Silicon Valley’s AI monopoly, a European alliance has emerged with an alternative to tech’s global order. They call their project OpenEuroLLM.